These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 8491051)

  • 21. [Pulsed doses of calcitriol in the treatment of secondary hyperparathyroidism in patients on hemodialysis].
    Sotorník I; Petrásek R; Schück O; Adamec M; Smrcková I; Tocík J
    Vnitr Lek; 1997 Sep; 43(9):584-91. PubMed ID: 9750467
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intravenous calcitriol lowers serum calcium concentrations in uraemic patients with severe hyperparathyroidism and hypercalcaemia.
    Hamdy NA; Brown CB; Kanis JA
    Nephrol Dial Transplant; 1989; 4(6):545-8. PubMed ID: 2507976
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Oral calcitriol pulse therapy in treatment of secondary hyperparathyroidism in patients with long term hemodialysis].
    Szołkiewicz M; Zdrojewski Z; Sulima-Gillow A; Rutkowski B
    Przegl Lek; 1996; 53(5):427-30. PubMed ID: 8754407
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intravenous paricalcitol for treatment of secondary hyperparathyroidism in children on hemodialysis.
    Greenbaum LA; Benador N; Goldstein SL; Paredes A; Melnick JZ; Mattingly S; Amdahl M; Williams LA; Salusky IB
    Am J Kidney Dis; 2007 Jun; 49(6):814-23. PubMed ID: 17533024
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Initial dosing of paricalcitol based on PTH levels in hemodialysis patients with secondary hyperparathyroidism.
    Mitsopoulos E; Zanos S; Ginikopoulou E; Kyriklidou P; Meimaridou D; Sakellariou G
    Am J Kidney Dis; 2006 Jul; 48(1):114-21. PubMed ID: 16797393
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of new vitamin D analogues on parathyroid function in chronically uraemic rats with secondary hyperparathyroidism.
    Hruby M; Ureña P; Mannstadt M; Schmitt F; Lacour B; Drüeke TB
    Nephrol Dial Transplant; 1996 Sep; 11(9):1781-6. PubMed ID: 8918622
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Calcitriol pulse therapy and histology of parathyroid glands in hemodialysis patients.
    Lomonte C; Martino R; Selvaggiolo M; Bona RM; Cazzato F; Milano R; Chiarulli G; Basile C
    J Nephrol; 2003; 16(5):716-20. PubMed ID: 14733419
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Increased in vitro and ex vivo proliferation of erythroid precursors induced by calcitriol in chronic renal failure. Synergistic effect with rHuEPO].
    Aucella F; Gatta G; Vigilante M; Scalzulli RP; Mantuano S; Carotenuto M; Stallone C
    G Ital Nefrol; 2002; 19(2):137-42. PubMed ID: 12195411
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sleep disturbances before and after parathyroidectomy for secondary hyperparathyroidism.
    Chou FF; Lee CH; Chen JB; Huang SC; Lee CT
    Surgery; 2005 Apr; 137(4):426-30. PubMed ID: 15800490
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A controlled trial of the early treatment of secondary hyperparathyroidism with calcitriol in hemodialysis patients.
    Delmez JA; Kelber J; Norwood KY; Giles KS; Slatopolsky E
    Clin Nephrol; 2000 Oct; 54(4):301-8. PubMed ID: 11076106
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Calcitriol pulse therapy is not more effective than daily calcitriol therapy in controlling secondary hyperparathyroidism in children with chronic renal failure. European Study Group on Vitamin D in Children with Renal Failure.
    Ardissino G; Schmitt CP; Testa S; Claris-Appiani A; Mehls O
    Pediatr Nephrol; 2000 Jul; 14(7):664-8. PubMed ID: 10912539
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of calcitriol on type 5b tartrate-resistant acid phosphatase and interleukin-6 in secondary hyperparathyroidism.
    Lu KC; Tseng CF; Wu CC; Yeung LK; Chen JS; Chao TY; Janckila AJ; Yam LT; Chu P
    Blood Purif; 2006; 24(5-6):423-30. PubMed ID: 16888370
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long-term evolution of the mineral metabolism after renal transplantation: a prospective, single-center cohort study.
    Van de Cauter J; Sennesael J; Haentjens P
    Transplant Proc; 2011 Nov; 43(9):3470-5. PubMed ID: 22099822
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Low-dose calcitriol prevents the rise in 1,84-iPTH without affecting serum calcium and phosphate in patients with moderate renal failure (prospective placebo-controlled multicentre trial).
    Ritz E; Küster S; Schmidt-Gayk H; Stein G; Scholz C; Kraatz G; Heidland A
    Nephrol Dial Transplant; 1995 Dec; 10(12):2228-34. PubMed ID: 8808216
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evidence of healing of secondary hyperparathyroidism in chronically hemodialyzed uremic patients treated with long-term intravenous calcitriol.
    Cannella G; Bonucci E; Rolla D; Ballanti P; Moriero E; De Grandi R; Augeri C; Claudiani F; Di Maio G
    Kidney Int; 1994 Oct; 46(4):1124-32. PubMed ID: 7861707
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Decreased blood lead levels after calcitriol treatment in hemodialysis patients with secondary hyperparathyroidism.
    Lu KC; Wu CC; Ma WY; Chen CC; Wu HC; Chu P
    Bone; 2011 Dec; 49(6):1306-10. PubMed ID: 21985997
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Calcitriol treatment attenuates inflammation and oxidative stress in hemodialysis patients with secondary hyperparathyroidism.
    Wu CC; Chang JH; Chen CC; Su SB; Yang LK; Ma WY; Zheng CM; Diang LK; Lu KC
    Tohoku J Exp Med; 2011 Mar; 223(3):153-9. PubMed ID: 21350317
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Microwave ablation: an effective treatment for mild-to-moderate secondary hyperparathyroidism in patients undergoing haemodialysis.
    Wang G; Liu S; Liu X; Qian L; Diao Z; Liu W
    Int J Hyperthermia; 2017 Dec; 33(8):946-952. PubMed ID: 28768451
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Oral calcitriol pulse therapy in hemodialysis patients. Effects on histomorphometry of bone in renal hyperparathyroidism].
    Sperschneider H; Humbsch K; Abendroth K
    Med Klin (Munich); 1997 Oct; 92(10):597-603. PubMed ID: 9446007
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hypocalcemia may not be essential for the development of secondary hyperparathyroidism in chronic renal failure.
    Lopez-Hilker S; Galceran T; Chan YL; Rapp N; Martin KJ; Slatopolsky E
    J Clin Invest; 1986 Oct; 78(4):1097-102. PubMed ID: 3760186
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.